Profile
Lixian Jiang is currently the Chief Operating Officer & Vice President at Cz Biomed Corp.
Prior to this, he worked as the Chief Operating Officer at Stem Cell Therapy International, Inc. and as the Chief Operating Officer-China Division at AmStem Corp.
He holds a doctorate degree from the University of South Florida.
Lixian Jiang active positions
| Companies | Position | Start |
|---|---|---|
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Operating Officer | - |
Former positions of Lixian Jiang
| Companies | Position | End |
|---|---|---|
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Chief Operating Officer | 09/02/2010 |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Corporate Officer/Principal | 09/02/2010 |
Training of Lixian Jiang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Commercial Services |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Health Technology |
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- Lixian Jiang
















